Analysis of these polymorphisms, particularly XRCC1 codon 399 Arg/Gln may help in identifying individuals at risk of developing ALL and providing an essential information source for future improvement of ALL treatment. Here, XRCC1 is linked to acute lymphoblastic leukemia.